Oral small molecule GLP-1 receptor agonist aleniglipron in people…
An oral pill form of GLP-1 drug shows weight-loss promise in early trials, potentially making this class of medicine more accessible globally than current injections.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Deep learning for H&E-based meningioma molecular classification and…
AI trained on routine tissue slides could predict brain tumor aggressiveness without expensive genetic testing, bringing precision diagnosis to under-resourced hospitals.
Near-term implementable findingPitfalls in detecting MET exon 14 skipping variants by DNA- and…
Clearer diagnostic guidelines for a lung cancer mutation help labs catch more patients eligible for targeted drugs, reducing missed treatment opportunities.
Near-term implementable findingPerformance Evaluation of GPT-5, Grok 4, and DeepSeek R1 in…
Current frontier AI models show mixed reliability for interpreting blood tests, offering clinicians concrete data for safe deployment in hematology practice.
Near-term implementable findingTargeted reflex RNA sequencing for enhanced variant classification on…
Adding RNA sequencing to genetic testing reduces confusing inconclusive results and shortens the diagnostic journey for patients with rare hereditary diseases.